Jerry S. Wolinsky
Impact in
- Pathology and Forensic Medicine top 0.01%
- Multiple Sclerosis Research Studies
- Neurology top 0.05%
- Peripheral Neuropathies and Disorders
Papers in
-
- Multiple Sclerosis Research Studies 177
- Rheumatology 64
- Rheumatoid Arthritis Research and Therapies 44
- Systemic Lupus Erythematosus Research 20
- Co-authors
- Fred Lublin (38 shared papers)Stephen C. Reingold (7 shared papers)Massimo Filippi (14 shared papers)Chris H. Polman (7 shared papers)Alan J. Thompson (4 shared papers)Magnhild Sandberg‐Wollheim (3 shared papers)Ludwig Kappos (69 shared papers)Paul O’Connor (18 shared papers)
- Journals
- Neurology (66 papers)Multiple Sclerosis Journal (36 papers)Annals of Neurology (17 papers)Multiple Sclerosis and Related Disorders (15 papers)Journal of Magnetic Resonance Imaging (11 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Jerry S. Wolinsky
237 papers receiving 27.7k citations
Jerry S. Wolinsky's Hit Papers
Peers
Comparison fields: 5 of 171
- Pathology and Forensic Medicine 23.4k
- Neurology 8.6k
- Rheumatology 6.5k
- Developmental Neuroscience 1.1k
- Neurology 2.1k
Countries citing papers authored by Jerry S. Wolinsky
This map shows the geographic impact of Jerry S. Wolinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry S. Wolinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry S. Wolinsky more than expected).
Fields of papers citing papers by Jerry S. Wolinsky
This network shows the impact of papers produced by Jerry S. Wolinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry S. Wolinsky. The network helps show where Jerry S. Wolinsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Jerry S. Wolinsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 243 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria Hit paper breakdown → | 2011 | 7607 |
| 2 | Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis Hit paper breakdown → | 2001 | 5442 |
| 3 | Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” Hit paper breakdown → | 2005 | 3977 |
| 4 | Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis Hit paper breakdown → | 2011 | 693 |
| 5 | European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group. Hit paper breakdown → | 2001 | 556 |
| 6 | 2001 | 480 | |
| 7 | Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2014 | 402 |
| 8 | Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials Hit paper breakdown → | 2020 | 344 |
| 9 | Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2016 | 335 |
| 10 | 2007 | 297 | |
| 11 | 2013 | 244 | |
| 12 | 1998 | 241 | |
| 13 | 2019 | 238 | |
| 14 | 1999 | 211 | |
| 15 | 2014 | 209 | |
| 16 | Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. | 2006 | 203 |
| 17 | 2012 | 188 | |
| 18 | 2007 | 159 | |
| 19 | 2013 | 159 | |
| 20 | 1983 | 155 |
About Jerry S. Wolinsky
Jerry S. Wolinsky is a scholar working on Pathology and Forensic Medicine, Rheumatology, Neurology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 243 papers that have together received 28.5k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (177 papers), Peripheral Neuropathies and Disorders (51 papers), Rheumatoid Arthritis Research and Therapies (44 papers), Systemic Lupus Erythematosus Research (20 papers), Ultrasound and Hyperthermia Applications (17 papers), Ultrasound Imaging and Elastography (14 papers), Polyomavirus and related diseases (14 papers) and Autoimmune and Inflammatory Disorders Research (12 papers). The work is most often cited by research in Pathology and Forensic Medicine (23.4k citations), Neurology (8.6k citations), Rheumatology (6.5k citations), Developmental Neuroscience (1.1k citations) and Neurology (2.1k citations). Jerry S. Wolinsky has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Fred Lublin, Stephen C. Reingold, Massimo Filippi, Chris H. Polman, Alan J. Thompson, Magnhild Sandberg‐Wollheim, Ludwig Kappos, Paul O’Connor, Brian G. Weinshenker and Hans‐Peter Hartung. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, Annals of Neurology, Multiple Sclerosis and Related Disorders and Journal of Magnetic Resonance Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.